Company research / SRTA

Strata Critical Medical, Inc. (SRTA)

CIK 0001779128 · Nasdaq · Services-Health Services

  • Sector Services
  • Incorporated DE
  • Fiscal year ends around Dec 31

For the year ended 2025-12-31, Strata Critical Medical, Inc. reported revenue of $197.14M. Revenue grew 34.3% from the prior annual period.

Key ratios (year ended 2025-12-31)

20.9%
Gross margin
-11.3%
Operating margin
21.0%
Net margin
14.8%
Return on year-end equity
34.3%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-09-25

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30
2025-12-312024-12-312023-12-312022-12-312021-12-312021-09-302020-12-312020-09-302020-06-302020-03-31
Revenuen/a$197.14M$146.82M$225.18M$146.12Mn/a$50.53Mn/a$23.43Mn/an/a
Cost of Revenuen/a$156.01M$117.23M$183.06M$123.84Mn/a$40.01Mn/a$21.11Mn/an/a
Gross Profit$54.40M$41.13M$29.59M$42.12M$22.27Mn/a$10.52Mn/a$2.33Mn/an/a
Operating Incomen/a-$22.35M-$22.52M-$68.12M-$53.53Mn/a-$24.09Mn/a-$10.36Mn/an/a
Depreciation & Amortization$16.29M$8.19M$5.96M$7.11M$5.72Mn/a$596.0Kn/a$526.0Kn/an/a
EBITDAn/a-$14.17M-$16.56M-$61.01M-$47.80Mn/a-$23.50Mn/a-$9.83Mn/an/a
Net Income$40.22M$41.35M-$27.31M-$56.08M-$27.26Mn/a-$40.05Mn/a-$10.16Mn/an/a
EPS (Diluted)n/a$0.50-$0.35-$0.76-$0.38n/a-$0.93n/a-$0.40n/an/a
Total Assets$332.70M$325.47M$256.68M$294.94M$325.02M$335.88M$343.39M$277.84M$17.71Mn/an/a
Total Liabilities$53.38M$46.40M$34.74M$60.64M$50.54M$44.51M$52.16M$46.78M$6.63Mn/an/a
Long-Term Debtn/an/an/an/a$0n/an/an/an/an/an/a
Shareholders' Equity$279.32M$279.07M$221.94M$234.30M$274.49M$291.37M$291.23M$5.00M$11.08M$5.00M$5.00M
Cash & Equivalents$16.32M$30.97M$18.38M$27.87M$41.34M$2.60M$6.95M$846.1K$12.16Mn/an/a
Operating Cash Flow-$36.03M-$48.91M-$2.52M-$32.35M-$37.13Mn/a-$15.62Mn/a-$10.82Mn/an/a
Capital Expendituresn/a$9.60M$30.86M$2.11M$730.0Kn/a$297.0Kn/a$377.0Kn/an/a
Free Cash Flown/a-$58.51M-$33.38M-$34.46M-$37.86Mn/a-$15.91Mn/a-$11.20Mn/an/a
Share Repurchasesn/a$0$244.0K$0n/an/an/an/an/an/an/a
Weighted Average Diluted Sharesn/a82.09M77.50M73.52M71.24Mn/a42.88Mn/a25.21Mn/an/a
EPS (Basic)n/a$0.50-$0.35-$0.76-$0.38n/a-$0.93n/a-$0.40n/an/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView